MODE OF ACTION OF THE NEUROTROPHIC FACTOR CDNF AS A POTENTIAL DRUG FOR PARKINSON'S DISEASE

被引：0
|
作者：
Kovaleva, V. [1 ]
Shpironok, O. [1 ]
Ivanova, L. [2 ]
Yu, L. -Y. [1 ]
Karelson, M. [2 ]
Saarma, M. [1 ]
机构：
[1] Univ Helsinki, Inst Biotechnol, HiLIFE, Helsinki, Finland
[2] Univ Tartu, Inst Chem, Tartu, Estonia
来源：
PARKINSONISM & RELATED DISORDERS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P 123
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [1] Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease
    Voutilainen, Merja H.
    Arumae, Urmas
    Airavaara, Mikko
    Saarma, Mart
    FEBS LETTERS, 2015, 589 (24): : 3739 - 3748
  • [2] Novel Neurotrophic Factor CDNF: Biology and Therapeutic Potential
    Saarma, M.
    Lindholm, P.
    Andressoo, J. -O.
    Perlinen, J.
    Lindahl, M.
    CELL TRANSPLANTATION, 2010, 19 (03) : 359 - 360
  • [3] Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease
    Susan R.Goulding
    Jayanth Anantha
    Louise M.Collins
    Aideen M.Sullivan
    Gerard W.O'Keeffe
    Neural Regeneration Research, 2022, 17 (01) : 38 - 44
  • [4] Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease
    Goulding, Susan R.
    Anantha, Jayanth
    Collins, Louise M.
    Sullivan, Aideen M.
    O'Keeffe, Gerard W.
    NEURAL REGENERATION RESEARCH, 2022, 17 (01) : 38 - 44
  • [5] Analysis of mutations and the association between polymorphisms in the cerebral dopamine neurotrophic factor (CDNF) gene and Parkinson disease
    Choi, Jung-Mi
    Hong, Jung-Hoon
    Chae, Min-Joo
    Ngyuen Phuoc Hung
    Kang, Hyun-Sook
    Ma, Hyeo-Il
    Kim, Yun Joong
    NEUROSCIENCE LETTERS, 2011, 493 (03) : 97 - 101
  • [6] Neurotrophic factor therapy for Parkinson's disease
    Bjorklund, Anders
    Cenci, M. Angela
    RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH, 2010, 184 : 237 - 264
  • [7] The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
    Susan R.Goulding
    Aideen M.Sullivan
    Gerard W.O'Keeffe
    Louise M.Collins
    Neural Regeneration Research, 2020, 15 (08) : 1432 - 1436
  • [8] Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson’s Disease
    Tingting Tang
    Yong Li
    Qian Jiao
    Xixun Du
    Hong Jiang
    Neuroscience Bulletin, 2017, 33 : 568 - 575
  • [9] The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
    Goulding, Susan R.
    Sullivan, Aideen M.
    O'Keeffe, Gerard W.
    Collins, Louise M.
    NEURAL REGENERATION RESEARCH, 2020, 15 (08) : 1432 - 1436
  • [10] Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease
    Tingting Tang
    Yong Li
    Qian Jiao
    Xixun Du
    Hong Jiang
    Neuroscience Bulletin, 2017, 33 (05) : 568 - 575
12345